Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arcturus Therapeutics Holdings Inc (NQ: ARCT ) 26.55 +0.38 (+1.45%) Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 275,687 Open 26.28 Bid (Size) 25.85 (1) Ask (Size) 28.81 (3) Prev. Close 26.17 Today's Range 25.84 - 26.86 52wk Range 17.52 - 43.81 Shares Outstanding 26,562,951 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 April 25, 2024 From Arcturus Therapeutics Holdings Inc. Via Business Wire The Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Experts March 11, 2024 Via Benzinga Performance YTD -19.76% -19.76% 1 Month -21.38% -21.38% 3 Month -21.05% -21.05% 6 Month +42.28% +42.28% 1 Year -0.26% -0.26% More News Read More ARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Misses Revenue for Q4 2023 March 07, 2024 Via InvestorPlace Recap: Arcturus Therapeutics Q4 Earnings March 07, 2024 Via Benzinga Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress March 07, 2024 From Arcturus Therapeutics Holdings Inc. Via Business Wire Earnings Preview: Arcturus Therapeutics March 06, 2024 Via Benzinga Evaluating NASDAQ:ARCT for Growth Investment Opportunities. February 27, 2024 Via Chartmill Earnings Scheduled For March 7, 2024 March 07, 2024 Via Benzinga Is NASDAQ:ARCT suited for growth investing? February 06, 2024 Via Chartmill 7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff February 26, 2024 Via InvestorPlace Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference February 26, 2024 From Arcturus Therapeutics Holdings Inc. Via Business Wire Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis February 22, 2024 From Arcturus Therapeutics Holdings Inc. Via Business Wire Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 February 21, 2024 Via InvestorPlace 3 Tech Stocks That Could Be Multibaggers in the Making: February Edition February 20, 2024 Via InvestorPlace Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024 February 20, 2024 From Arcturus Therapeutics Holdings Inc. Via Business Wire New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster February 05, 2024 From Arcturus Therapeutics Via Business Wire Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session January 23, 2024 Via Benzinga Topics Stocks Exposures US Equities Why the growth investor may take a look at ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT). January 16, 2024 Via Chartmill ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) showing high EPS and FCF growth while beating expectations December 26, 2023 Via Chartmill CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster December 21, 2023 From Arcturus Therapeutics Via Business Wire 7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar December 17, 2023 Via InvestorPlace 3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024 December 13, 2023 Via InvestorPlace Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside December 13, 2023 Via Benzinga 5 Value Stocks In The Healthcare Sector December 04, 2023 Via Benzinga Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 04, 2023 From Arcturus Therapeutics Holdings Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.